Search Results - "Chatterjee, Manash"

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Systems Biology of Coagulation Initiation: Kinetics of Thrombin Generation in Resting and Activated Human Blood.

Authors: Chatterjee, Manash S. Denney, William S. Huiyan Jing et al.

Source: PLoS Computational Biology. Sep2010, Vol. 6 Issue 9, p1-24. 24p. 1 Diagram, 2 Charts, 9 Graphs.

Population Pharmacokinetic Modeling and Exposure‐Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies.

Authors: Kemal, Chiara C. Zweers, Thijs J. Krekels, Elke H. J. et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. May2026, Vol. 15 Issue 5, p1-12. 12p.

Reduced expression of a protein homologous to glycogenin leads to reduction of starch content in Arabidopsis leaves

Authors: Chatterjee, Manash Berbezy, Pierre Vyas, Darshna et al.

Source: Plant Science. Feb2005, Vol. 168 Issue 2, p501-509. 9p.

EFFECTS OF LONGER-TERM TREATMENT WITH ANACETRAPIB ON SAFETY PARAMETERS, LIPIDS, AND PLASMA DRUG CONCENTRATIONS IN THE DEFINE TRIAL.

Authors: Gotto, Antonio Chatterjee, Manash Shankar Liu, Yang et al.

Source: Journal of the American College of Cardiology (JACC). Apr2014 Supplement, Vol. 63, pA1449-A1449. 1p.

A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population.

Authors: Zweers, Thijs J. Lommerse, Jos van Maanen, Eline et al.

Source: Clinical Pharmacokinetics. Oct2024, Vol. 63 Issue 10, p1489-1499. 11p.

Multiscale prediction of patient-specific platelet function under flow.

Authors: Flamm, Matthew H. Colace, Thomas V. Chatterjee, Manash S. et al.

Source: Blood. 7/5/2012, Vol. 120 Issue 1, p190-198. 9p.

TILLING by Sequencing (TbyS) for targeted genome mutagenesis in crops.

Authors: Kumar, Anishkumar McKeown, Peter Boualem, Adnane et al.

Source: Molecular Breeding. Feb2017, Vol. 37 Issue 2, p1-12. 12p.

Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target.

Authors: Ankrom, Wendy Wood, Harold B. Xu, Jiayi et al.

Source: Pharmacology Research & Perspectives. Feb2016, Vol. 4 Issue 1, pn/a-N.PAG. 13p.

Development of a Cucumis sativus TILLinG Platform for Forward and Reverse Genetics.

Authors: Boualem, Adnane Fleurier, Sebastien Troadec, Christelle et al.

Source: PLoS ONE. May2014, Vol. 9 Issue 5, p1-8. 8p.

PT-Flax (phenotyping and TILLinG of flax): development of a flax (Linum usitatissimum L.) mutant population and TILLinG platform for forward and reverse genetics.

Authors: Chantreau, Maxime Grec, Sébastien Gutierrez, Laurent et al.

Source: BMC Plant Biology. 2013, Vol. 13 Issue 1, p1-33. 33p.

SMART - Sunflower Mutant population And Reverse genetic Tool for crop improvement.

Authors: Kumar, Anish P. K. Boualem, Adnane Bhattacharya, Anjanabha et al.

Source: BMC Plant Biology. 2013, Vol. 13 Issue 1, p1-8. 8p. 2 Color Photographs, 4 Charts, 1 Graph.

Characterisation of disproportionating enzyme from wheat endosperm.

Authors: Bresolin, Nicole Li, Zhongyi Kosar-Hashemi, Behjat et al.

Source: Planta: An International Journal of Plant Biology. Jul2006, Vol. 224 Issue 1, p20-31. 12p. 1 Chart, 7 Graphs.

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.

Authors: Sandhu, Shahneen K Schelman, William R Wilding, George et al.

Source: Lancet Oncology. Aug2013, Vol. 14 Issue 9, p882-892. 11p.

Soluble starch synthase I: a major determinant for the synthesis of amylopectin in Arabidopsis thaliana leaves.

Authors: Delvallé, David Dumez, Sylvain Wattebled, Fabrice et al.

Source: Plant Journal. Aug2005, Vol. 43 Issue 3, p398-412. 15p.

Mutants of Arabidopsis Lacking a Chloroplastic Isoamylase Accumulate Phytoglycogen and an Abnormal Form of Amylopectin.

Authors: Wattebled, Fabrice Ying Dong Dumez, Sylvain et al.

Source: Plant Physiology. May2005, Vol. 138 Issue 1, p184-195. 12p. 7 Color Photographs, 4 Diagrams, 1 Chart, 24 Graphs.

Discovery of MK-1088 as a Potent A2A/A2B Adenosine Receptor Dual-Antagonist for Cancer Immunotherapy.

Authors: Zhang Y Hennessy E Larsen MA et al.

Source: Journal of medicinal chemistry [J Med Chem] 2026 May 14; Vol. 69 (9), pp. 10338-10359. Date of Electronic Publication: 2026 May 05.

Publication Type: Journal Article

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants.

Authors: Gupta P Chatterjee M Kim Y et al.

Source: Investigational new drugs [Invest New Drugs] 2024 Oct; Vol. 42 (5), pp. 492-499. Date of Electronic Publication: 2024 Aug 10.

Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE